West on Lung Cancer

H. Jack West, MD, is an Associate Clinical Professor and the Executive Director of Employer Services at City of Hope Comprehensive Cancer Center in Duarte, CA. He is also the web editor of JAMA Oncology and the founder and president of the nonprofit organization Global Resource for Advancing Cancer Education (GRACE), which provides information for patients and caregivers dealing with cancer. Dr West leads a wide range of continuing medical education programs and other educational programs, including hosting the audio podcast, West Wind.

+ Add to Email Alerts

Twitter Polls: Tapping Into the Wisdom of Crowds Oncologist Jack West explores the powerful benefits of Twitter polls.
Medscape Oncology, April 14, 2022
Is a PFS Benefit Alone Really Worth $10,000 a Month? Oncologist H. Jack West explores whether and when to consider surrogate endpoints to be practice-changing.
Medscape Oncology, March 02, 2022
Swinging for the Fences: Curing NSCLC Oncologist Jack West explores the major advances we've made in treating NSCLC and makes predictions for what's to come in the curative setting.
Medscape Oncology, January 20, 2022
Too Soon to Utter the Word 'Cure' in Advanced Lung Cancer? Oncologist Jack West explores whether it's appropriate to use the word "cure" for some patients with advanced lung cancer.
Medscape Oncology, November 16, 2021
When Phase 3 Data Can't Guide Oncology Decision-Making Oncologist Jack West explores the limits of phase 3 data to provide clear treatment options for the many subgroups of patients.
Medscape Oncology, October 14, 2021
Can Telemedicine Survive? The future of telemedicine remains uncertain. Oncologist Jack West explores how we can give this approach staying power.
Medscape Oncology, September 15, 2021
Oncologists Still Failing 'Woefully' at Molecular Testing Oncologist Jack West explores why molecular testing in advanced lung cancer is not happening often enough in the clinic
Medscape Oncology, September 14, 2021
Is There a Fix for Willful Medical Ignorance? The widespread rejection of science is now a leading bottleneck in the progress of medicine, argues oncologist Jack West.
Medscape Oncology, August 23, 2021
Telemedicine Beyond the Pandemic Telemedicine has long-term potential to close gaps in healthcare -- once we resolve the glitches.
Medscape Oncology, July 06, 2021
The Dangers of Incentivizing Mediocrity With 'Me-Too' Drugs Dr Jack West warns us about the very real costs of asking so little of pivotal trials for redundant cancer treatments.
Medscape Oncology, April 16, 2021
Sifting Through the Wreckage of 2020: 5 Things Worth Salvaging Treating cancer demands celebrating successes where you can find them. An oncologist looks back at a few of the beneficial adaptations that happened despite an otherwise abysmal year.
Medscape Oncology, February 08, 2021
Identity Onco-Politics Is Impairing Our Objectivity We must avoid reflexively toeing a party line when interpreting data, says Dr Jack West.
Medscape Oncology, February 03, 2021
Happy Days in Oncology: More Applause, Less Rigor? Dr Jack West worries that in our quest for positive outcomes, we've stopped being thought leaders and become cheerleaders instead.
Medscape Oncology, December 01, 2020
Oncology Is Not Immune From Online 'Confirmation Bias' Far too often, online discussions among oncologists cross the line into specious and even dangerous territory.
Medscape Oncology, October 15, 2020
5 Reasons Why Medical Meetings Will Never Be the Same Dr Jack West argues that we shouldn't necessarily rush to return to the previous status quo of live, in-person medical meetings.
Medscape Oncology, September 09, 2020
Why Are Oncologists Deviating From Best Evidence in NSCLC? Bringing practices in line with standard of care requires understanding why they're diverging in the first place, says Dr Jack West.
Medscape Oncology, August 18, 2020
We Can't Afford to Be 'Cost-Agnostic' With Our Cancer Patients Dr Jack West on how one oncologist's personal experience propelled her to make patients' financial hardships a viable treatment consideration.
Medscape Oncology, June 11, 2020
ADAURA Trial: Breaking Through the Hype Drs Jack West and Lecia Sequist discuss the pros and cons of the ADAURA trial, and whether focusing on only disease-free survival is enough for patients with EGFR mutation-positive NSCLC.
Medscape Oncology, June 05, 2020
Has 'Patient Centeredness' Gone Too Far? Patient centeredness is not a reason to accede to misguided medical decisions, argues Jack West.
Medscape Oncology, May 29, 2020
Why Is the UK so Much Better at Molecular Profiling? Drs Jack West and Sanjay Popat discuss the strengths and limitations of their respective US and UK systems for identifying and treating lung cancer with actionable mutations.
Medscape Oncology, May 08, 2020

No Results